Bioequivalency Study of Levetiracetam 750 mg Tablets Under Fasting Conditions



Status:Completed
Conditions:Neurology
Therapuetic Areas:Neurology
Healthy:No
Age Range:18 - 45
Updated:1/25/2018
Start Date:August 2005
End Date:August 2005

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Levetiracetam 750 mg Tablets Under Fasting Conditions

The objective of this study was to prove the bioequivalence of Levetiracetam 750 mg Tablets
under fasted conditions


Inclusion Criteria:

- No clinically significant abnormal findings on the physical examination, medical
history, or clinical laboratory results during screening

Exclusion Criteria:

- Positive test for HIV, Hepatitis B, or Hepatitis C. Treatment with known enzyme
altering drugs. History of allergic or adverse response to Levetiracetam or any
comparable or similar product.
We found this trial at
1
site
MDS Pharma Services
Phoenix, Arizona 85044
?
mi
from
Phoenix, AZ
Click here to add this to my saved trials